tiprankstipranks
Galapagos and  Adaptimmune in clinical collaboration agreement for uza-cel
PremiumThe FlyGalapagos and Adaptimmune in clinical collaboration agreement for uza-cel
2M ago
Galapagos price target lowered to EUR 30 from EUR 33 at Barclays
PremiumThe Fly
Galapagos price target lowered to EUR 30 from EUR 33 at Barclays
2M ago
Galapagos NV Announces New Employee Benefits Plan
PremiumCompany Announcements
Galapagos NV Announces New Employee Benefits Plan
2M ago
Galapagos announces clinical/ translational data on hematological cancer care
PremiumThe FlyGalapagos announces clinical/ translational data on hematological cancer care
3M ago
Crocs initiated, Bill downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Crocs initiated, Bill downgraded: Wall Street’s top analyst calls
4M ago
Galapagos downgraded to Underperform from Neutral at BofA
PremiumThe Fly
Galapagos downgraded to Underperform from Neutral at BofA
4M ago
Galapagos price target lowered to $41 from $44 at BofA
PremiumThe FlyGalapagos price target lowered to $41 from $44 at BofA
5M ago
Galapagos price target lowered to EUR 33 from EUR 37 at Barclays
PremiumThe Fly
Galapagos price target lowered to EUR 33 from EUR 37 at Barclays
5M ago
Galapagos reports FY23 revenue EUR 543.8M vs EUR 264M last year
PremiumThe Fly
Galapagos reports FY23 revenue EUR 543.8M vs EUR 264M last year
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100